$0.880100
-0.0099-1.11%
Pre-Market: 7:13 PM EDT
15 minutes delayed
Xilio Therapeutics
XLONASDAQ
Xilio Therapeutics (XLO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestXilio Therapeutics (NASDAQ:XLO) Stock Quotes, Forecast and News Summary
Xilio Therapeutics Stock (NASDAQ: XLO) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 447.79K |
| Day Range | - - - |
| 52 Wk Range | 0.49 - 2.94 |
| Market Cap | $32.49M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 0.26% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Xilio Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-ac...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Xilio Therapeutics (XLO) stock?
You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.
Who are Xilio Therapeutics (XLO) competitors?
Other companies in Xilio Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX) and Curis (NASDAQ:CRIS).
What is the target price for Xilio Therapeutics (XLO) stock?
There is no analysis for Xilio Therapeutics.
What is the forecast for Xilio Therapeutics (XLO) stock?
Xilio Therapeutics has a consensus price target of $13.20.
Current stock price for Xilio Therapeutics (XLO)?
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $0.8801 last updated July 2, 2024 at 7:13 PM EDT.
Does Xilio Therapeutics (XLO) pay a dividend?
There are no upcoming dividends for Xilio Therapeutics.
When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?
Xilio Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Xilio Therapeutics (XLO) going to split?
There is no upcoming split for Xilio Therapeutics.
What sector and industry does Xilio Therapeutics (XLO) operate in?
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.